Wednesday, November 25, 2015 11:12:44 AM
Normally Dennis this would be the logical question.... but given the mess this CEO has created with his financials It's my belief the answer is that he has no cash to pay the OTC/audit fee's ...Inventory issues is the absolute very least of his and the "INFAMOUS & COMPLICIT GALPAL's" complications. This idiot hasn't 2 pennies to rub together What ever is left and laying around of the 12 million mysterious dollars that disappeared keeps the GALPAL on the "job" as the Int'l sales mgr that has no Int'l sales that amounts to anything at all.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM